The candidates that received fast track status are the most advanced of four potential vaccines being developed jointly by the two companies.
Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines ‘fast track’ status
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over